739 related articles for article (PubMed ID: 29143791)
1. Dietary and Endogenous Sphingolipid Metabolism in Chronic Inflammation.
Norris GH; Blesso CN
Nutrients; 2017 Oct; 9(11):. PubMed ID: 29143791
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Dietary Sphingolipids on Intestinal Microbiota and Gastrointestinal Immune Homeostasis.
Rohrhofer J; Zwirzitz B; Selberherr E; Untersmayr E
Front Immunol; 2021; 12():635704. PubMed ID: 34054805
[TBL] [Abstract][Full Text] [Related]
3. Network Analysis of a Comprehensive Knowledge Repository Reveals a Dual Role for Ceramide in Alzheimer's Disease.
Mizuno S; Ogishima S; Kitatani K; Kikuchi M; Tanaka H; Yaegashi N; Nakaya J
PLoS One; 2016; 11(2):e0148431. PubMed ID: 26849355
[TBL] [Abstract][Full Text] [Related]
4. Gene expression of sphingolipid metabolism pathways is altered in hidradenitis suppurativa.
Dany M; Elston D
J Am Acad Dermatol; 2017 Aug; 77(2):268-273.e6. PubMed ID: 28551069
[TBL] [Abstract][Full Text] [Related]
5. Sphingolipids in inflammation: roles and implications.
Pettus BJ; Chalfant CE; Hannun YA
Curr Mol Med; 2004 Jun; 4(4):405-18. PubMed ID: 15354871
[TBL] [Abstract][Full Text] [Related]
6. Sphingolipids in inflammation: pathological implications and potential therapeutic targets.
Nixon GF
Br J Pharmacol; 2009 Oct; 158(4):982-93. PubMed ID: 19563535
[TBL] [Abstract][Full Text] [Related]
7. Dietary sphingolipids: potential for management of dyslipidemia and nonalcoholic fatty liver disease.
Norris GH; Blesso CN
Nutr Rev; 2017 Apr; 75(4):274-285. PubMed ID: 28383715
[TBL] [Abstract][Full Text] [Related]
8. Sphingolipid metabolites in inflammatory disease.
Maceyka M; Spiegel S
Nature; 2014 Jun; 510(7503):58-67. PubMed ID: 24899305
[TBL] [Abstract][Full Text] [Related]
9. Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology.
Merrill AH; Schmelz EM; Dillehay DL; Spiegel S; Shayman JA; Schroeder JJ; Riley RT; Voss KA; Wang E
Toxicol Appl Pharmacol; 1997 Jan; 142(1):208-25. PubMed ID: 9007051
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory response and its relation to sphingolipid metabolism proteins: Chaperones as potential indirect anti-inflammatory agents.
Yagci ZB; Esvap E; Ozkara HA; Ulgen KO; Olmez EO
Adv Protein Chem Struct Biol; 2019; 114():153-219. PubMed ID: 30635081
[TBL] [Abstract][Full Text] [Related]
11. Adipose tissue and ceramide biosynthesis in the pathogenesis of obesity.
Samad F; Badeanlou L; Shah C; Yang G
Adv Exp Med Biol; 2011; 721():67-86. PubMed ID: 21910083
[TBL] [Abstract][Full Text] [Related]
12. Sphingolipid metabolism, oxidant signaling, and contractile function of skeletal muscle.
Nikolova-Karakashian MN; Reid MB
Antioxid Redox Signal; 2011 Nov; 15(9):2501-17. PubMed ID: 21453197
[TBL] [Abstract][Full Text] [Related]
13. Dietary sphingolipids improve skin barrier functions via the upregulation of ceramide synthases in the epidermis.
Duan J; Sugawara T; Hirose M; Aida K; Sakai S; Fujii A; Hirata T
Exp Dermatol; 2012 Jun; 21(6):448-52. PubMed ID: 22621186
[TBL] [Abstract][Full Text] [Related]
14. A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis.
Quinville BM; Deschenes NM; Ryckman AE; Walia JS
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071409
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of sphingolipids in the gut and its relation to inflammation and cancer development.
Duan RD; Nilsson A
Prog Lipid Res; 2009 Jan; 48(1):62-72. PubMed ID: 19027789
[TBL] [Abstract][Full Text] [Related]
16. Sphingolipid synthetic pathways are major regulators of lipid homeostasis.
Worgall TS
Adv Exp Med Biol; 2011; 721():139-48. PubMed ID: 21910087
[TBL] [Abstract][Full Text] [Related]
17. Fostering Inflammatory Bowel Disease: Sphingolipid Strategies to Join Forces.
Abdel Hadi L; Di Vito C; Riboni L
Mediators Inflamm; 2016; 2016():3827684. PubMed ID: 26880864
[TBL] [Abstract][Full Text] [Related]
18. Sphingolipid Metabolism and Signaling in Skeletal Muscle: From Physiology to Physiopathology.
Tan-Chen S; Guitton J; Bourron O; Le Stunff H; Hajduch E
Front Endocrinol (Lausanne); 2020; 11():491. PubMed ID: 32849282
[TBL] [Abstract][Full Text] [Related]
19. Sphingolipid metabolism and neutral sphingomyelinases.
Airola MV; Hannun YA
Handb Exp Pharmacol; 2013; (215):57-76. PubMed ID: 23579449
[TBL] [Abstract][Full Text] [Related]
20. Role of dietary sphingolipids and inhibitors of sphingolipid metabolism in cancer and other diseases.
Merrill AH; Schmelz EM; Wang E; Schroeder JJ; Dillehay DL; Riley RT
J Nutr; 1995 Jun; 125(6 Suppl):1677S-1682S. PubMed ID: 7782925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
